Share this article
Share this article
SAN CARLOS, Calif. and BOULDER, Colo., May 26, 2021 /PRNewswire/ Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, and Addario Lung Cancer Medical Institute (ALCMI) today announced they will present on the progress of Biomarker Analysis in High PD-L1 Expressing NSCLC Patients Treated With PD-1/PD-L1 Based Therapy With or Without the Addition of Platinum Based Chemotherapy (BEACON-Lung). The BEACON-Lung study aims to evaluate biomarkers to predict overall survival and early progression outcomes in treatment-naïve advanced stage non-small cell lung cancer (NSCLC) patients with high PD-L1 expression. The first patient participant enrolled in the study this week.
MemorialCare Acquires OC Blood & Cancer Care
Prominent Orange County Physician Group Serving Thousands of Patients with Cancer and Blood Diseases Chooses to Join MemorialCare Medical Group, Expand Access to Local Medical Services
News provided by
Share this article
Share this article
ORANGE COUNTY, Calif., Jan. 13, 2021 /PRNewswire/ MemorialCare, the largest nonprofit healthcare system headquartered in Orange County, acquired OC Blood & Cancer Care, a prominent, nationally recognized group of board-certified oncologists and hematologists treating cancer and blood diseases in locations in Laguna Hills and Fountain Valley and at MemorialCare Cancer Institute facilities.
OC Blood & Cancer Care, nationally recognized board-certified oncologists and hematologists treating cancer and blood diseases in locations in Laguna Hills and Fountain Valley and at MemorialCare Cancer Institute facilities, include (clockwise from top left) Jack Jacoub, M.D.; Amol Rao, M.D.; Sarah Hassan, M.D.